MRP4 (ABCC4) as a potential pharmacologic target for cardiovascular disease

Pharmacological Research

Volumn 107, Issue , 2016, Pages 381-389

  Belleville Rolland, Tiphaine ^a,b,c   Sassi, Yassine ^d   Decouture, Benoit ^a,b   Dreano, Elise ^a,b   Hulot, Jean Sébastien ^e,f   Gaussem, Pascale ^a,b,c   Bachelot Loza, Christilla ^a,b  

^a Fondation Carpentier   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^e PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^f SORBONNE UNIVERSITÉ   (France)

Author keywords

ABCC4; cAMP; Cardiovascular diseasea; MRP4; Platelet; Thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE; ADENYLATE CYCLASE; CYCLIC AMP; CYCLIC NUCLEOTIDE; MULTIDRUG RESISTANCE ASSOCIATED PROTEIN 4; ABCC4 PROTEIN, HUMAN; MULTIDRUG RESISTANCE PROTEIN;

CARDIOVASCULAR DISEASE; CELL COMPARTMENTALIZATION; CELL GRANULE; CELL LEVEL; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CORONARY ARTERY SMOOTH MUSCLE CELL; CYTOSOL; DRUG TARGETING; ENZYME ACTIVATION; GENE SILENCING; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; HEART MUSCLE FIBROSIS; HEART VENTRICLE HYPERTROPHY; HUMAN; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PULMONARY ARTERY SMOOTH MUSCLE CELL; REVIEW; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE ANOMALY; THROMBOSIS; VASCULAR BIOLOGY; VASCULAR SMOOTH MUSCLE CELL; VASODILATATION; ANIMAL; METABOLISM;

ANIMALS; BLOOD PLATELETS; CARDIOVASCULAR DISEASES; HUMANS; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS;

EID: 84962910030     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2016.04.002     Document Type: Review

References (73)

1. Z. Sauna, I. Kim, K. Nandigama, S. Kopp, P. Chiba, and S. Ambudkar Catalytic cycle of ATP hydrolysis by P-glycoprotein: evidence for formation of the E.S. reaction intermediate with ATP-gamma-S, a nonhydrolyzable analogue of ATP Biochemistry 46 2007 13787 13799
2. A. Siarheyeva, R. Liu, and F. Sharom Characterization of an asymmetric occluded state of P-glycoprotein with two bound nucleotides: implications for catalysis J. Biol. Chem. 285 2010 7575 7586
3. N. Abla, L. Chinn, T. Nakamura, L. Liu, C. Huang, S. Johns, and et al. The human multidrug resistance protein 4 (MRP4, ABCC4): functional analysis of a highly polymorphic gene J. Pharmacol. Exp. Ther. 325 2008 859 868
4. G. Denk, C. Soroka, Y. Takeyama, W. Chen, J. Schuetz, and J. Boyer Multidrug resistance-associated protein 4 is up-regulated in liver but down-regulated in kidney in obstructive cholestasis in the rat J. Hepatol. 40 2004 585 591
5. U. Gradhand, T. Lang, E. Schaeffeler, H. Glaeser, H. Tegude, K. Klein, and et al. Variability in human hepatic MRP4 expression: influence of cholestasis and genotype Pharmacogenomics J. 8 2008 42 52
6. J. Schuetz, M. Connelly, D. Sun, S. Paibir, P. Flynn, R. Srinivas, and et al. MRP4: a previously unidentified factor in resistance to nucleoside-based antiviral drugs Nat. Med. 5 1999 1048 1051
7. N. Galie, B. Brundage, H. Ghofrani, R. Oudiz, G. Simonneau, Z. Safdar, and et al. Tadalafil therapy for pulmonary arterial hypertension Circulation 19 2009 2894 2903
8. N. Galie, H. Ghofrani, A. Torbicki, R. Barst, L. Rubin, D. Badesch, and et al. Sildenafil citrate therapy for pulmonary arterial hypertension N. Engl. J. Med. 353 2005 2148 2157
9. Y. Sassi, L. Lipskaia, G. Vandecasteele, V. Nikolaev, S. Hatem, F. Aubart, and et al. Multidrug resistance-associated protein 4 regulates cAMP-dependent signaling pathways and controls human and rat SMC proliferation J. Clin. Invest. 118 2008 2747 2757
10. Y. Hara, Y. Sassi, C. Guibert, N. Gambaryan, P. Dorfmüller, S. Eddahibi, and et al. Inhibition of MRP4 prevents and reverses pulmonary hypertension in mice J. Clin. Invest. 121 2011 2888 2897
11. D. Cheng, J. Ren, and E. Jackson Multidrug resistance protein 4 mediates cAMP efflux from rat preglomerular vascular smooth muscle cells Clin. Exp. Pharmacol. Physiol. 37 2010 205 207
12. Z. Sellers, A. Naren, Y. Xiang, and P. Best MRP4 and CFTR in the regulation of cAMP and béta-adrenergic contraction in cardiac myocytes Eur. J. Pharmacol. 681 2012 80 87
13. Y. Sassi, A. Abi-Gerges, J. Fauconnier, N. Mougenot, S. Reiken, K. Haghighi, and et al. Regulation of cAMP homeostasis by the efflux protein MRP4 in cardiac myocytes FASEB J. 26 2012 1009 1017
14. Y. Sassi, A. Ahles, D. Truong, Y. Baqi, S. Lee, B. Husse, and et al. Cardiac myocyte - secreted cAMP exerts paracrine action via adenosine receptor activation J. Clin. Invest. 124 2014 5385 5397
15. E. Jackson, and D. Raghvendra The extracellular cyclic AMP-adenosine pathway in renal physiology Annu. Rev. Physiol. 66 2004 571 599
16. E. Gorin, and T. Brenner Extracellular metabolism of cyclic AMP Biochim. Biophys. Acta Biomembr. 451 1976 20 28
17. J. Smoake, K.L. McMahon, R. Wright, and S. Solomon Hormonally sensitive cyclic AMP phosphodiesterase in liver cells. An ecto-enzyme J. Biol. Chem. 256 1981 8531 8535
18. P. Rosenberg, and M. Dichter Extracellular cAMP accumulation and degradation in rat cerebral cortex in dissociated cell culture J. Neurosci. 9 1989 2654 2663
19. P. Rosenberg, R. Knowles, K. Knowles, and Y. Li Beta-adrenergic aeceptor-mediated regulation of extracellular adenosine in cerebral cortex in culture J. Neurosci. 4 1994 2953 2965
20. P. Rosenberg, and Y. Li Adenylyl cyclase activation underlies intracellular cyclic AMP accumulation, cyclic AMP transport, and extracellular adenosine accumulation evoked by béta-adrenergic receptor stimulation in mixed cultures of neurons and astrocytes derived from rat cerebral cortex Brain Res. 617 1995 227 232
21. T. Chiavegatti, V. Costa, M. Araújo, and R. Godinho Skeletal muscle expresses the extracellular cyclic AMP-adenosine pathway Br. J. Pharmacol. 153 2008 1331 1340
22. R. Dubey, D. Gillespie, H. Shue, and E. Jackson A2B receptors mediate antimitogenesis in vascular smooth muscle cells Hypertension 35 2000 267 272
23. R. Dubey, D. Gillespie, Z. Mi, and E. Jackson Cardiac fibroblasts express the cAMP-adenosine pathway Hypertension 36 2000 337 342
24. R. Dubey, D. Gillespie, and E. Jackson Cyclic AMP-adenosine pathway induces nitric oxide synthesis in aortic smooth muscle cells Hypertension 31 1998 296 302
25. H. Kather Beta-adrenergic stimulation of adenine nucleotide catabolism and purine release in human adipocytes J. Clin. Invest. 85 1990 106 114
26. D. Sim, G. Merrill-Skoloff, B. Furie, B. Furie, and R. Flaumenhaft Initial accumulation of platelets during arterial thrombus formation in vivo is inhibited by elevation of basal cAMP levels Blood 103 2004 2127 2134
27. M.W. Radomski, R.M. Palmer, and S. Moncada Comparative pharmacology of endothelium-derived relaxing factor, nitric oxide and prostacyclin in platelets Br. J. Pharmacol. 92 1987 181 187
28. J. Rowley, A. Oler, N. Tolley, B. Hunter, E. Low, D. Nix, and et al. Genome wide RNA-seq analysis of human and mouse platelet transcriptomes e-Blood 118 2011 e101 e111
29. J. Burkhart, M. Vaudel, S. Gambaryan, S. Radau, U. Walter, L. Martens, and et al. The first comprehensive and quantitative analysis of human platelet protein composition allows the comparative analysis of structural and functional pathways e-Blood 120 2012 e73 82
30. W. Dostmann, and S. Taylor Identifying the molecular switches that determine whether (Rp)-cAMPS functions as an antagonist or an agonist in the activation of cAMP-dependent protein kinase I Biochemistry 30 1991 8710 8716
31. R. Waldmann, M. Nieberding, and U. Walter Vasodilator-stimulated protein phosphorylation in platelets is mediated by cAMP- and cGMP-dependent protein kinases Eur. J. Biochem. 167 1987 441 448
32. A. Aburima, K. Wraith, Z. Raslan, R. Law, S. Magwenzi, and K. Naseem cAMP signaling regulates platelet myosin light chain (MLC) phosphorylation and shape change through targeting the RhoA- Rho kinase-MLC phosphatase signaling pathway Blood 122 2013 3533 3545
33. 2+ release from platelet internal membranes is regulated by differential phosphorylation Biochemistry 35 1996 6865 6871
34. 2+ release by cAMP-dependent protein kinase in a living cell Proc. Natl. Acad. Sci. U. S. A. 95 1998 1613 1617
35. S. Loyau, B. Dumont, V. Ollivier, Y. Boulaftali, L. Feldman, N. Ajzenberg, and et al. Platelet glycoprotein VI dimerization, an active process inducing receptor competence, is an indicator of platelet reactivity Arterioscler. Thromb. Vasc. Biol. 32 2012 778 785
36. S. Stroop, and J. Beavo Structure and function studies of the cGMP-stimulated phosphodiesterase J. Biol. Chem. 266 1991 23802 23809
37. I. Turko, S. Francis, and J. Corbin Binding of cGMP to both allosteric sites of cGMP-binding cGMP-specific phosphodiesterase (PDE5) is required for its phosphorylation Biochem. J. 329 1998 505 510
38. J. Yang, J. Wu, M. Kowalska, A. Dalvi, N. Prevost, P. O'Brien, and et al. Loss of signaling through the G protein, Gz, results in abnormal platelet activation and altered responses to psychoactive drugs Proc. Natl. Acad. Sci. U. S. A. 97 2000 9984 9989
39. B. Hechler, and C. Gachet Purinergic receptors in thrombosis and inflammation Arterioscler. Thromb. Vasc. Biol. 35 2015 2307 2315
40. L. Margarucci, M. Roest, C. Preisinger, O. Bleijerveld, T. van Holten, A. Heck, and et al. Collagen stimulation of platelets induces a rapid spatial response of cAMP and cGMP signaling scaffolds Mol. Biosyst. 7 2011 2311 2319
41. J. Esseltine, and J. Scott AKAP signaling complexes: pointing towards the next generation of therapeutic targets? Trends Pharmacol. Sci. 34 2013 648 655
42. S. El-Daher, M. Eigenthaler, U. Walter, T. Furuichi, A. Miyawaki, K. Mikoshiba, and et al. Distribution and activation of cAMP- and cGMP-dependent protein kinases in highly purified human platelet plasma and intracellular membranes Thromb. Haemost. 76 1996 1063 1071
43. S. El-Daher, Y. Patel, A. Siddiqua, S. Hassock, S. Edmunds, B. Maddison, and et al. Distinct localization and function of (1,4,5)IP(3) receptor subtypes and the (1,3,4,5)IP(4) receptor GAP1(IP4BP) in highly purified human platelet membranes Blood 95 2000 3412 3422
44. D. Dorahy, L. Lincz, C. Meldrum, and G. Burns Biochemical isolation of a membrane microdomain from resting platelets highly enriched in the plasma membrane glycoprotein CD36 Biochem. J. 319 1996 67 72
45. S. Bodin, H. Tronchère, and B. Payrastre Lipid rafts are critical membrane domains in blood platelet activation processes Biochim. Biophys. Acta Biomembr. 1610 2003 247 257
46. T.M. Quinton, S. Kim, J. Jin, and S.P. Kunapuli Lipid rafts are required in Galphai signaling downstream of the P2Y12 receptor during ADP-mediated platelet activation J. Thromb. Haemost. 3 2005 1036 1041
47. C.N. Shrimpton, G. Borthakur, S. Larrucea, M.A. Cruz, J.-F. Dong, and J.A. López Localization of the adhesion receptor glycoprotein Ib-IX-V complex to lipid rafts is required for platelet adhesion and activation J. Exp. Med. 8 2002 1057 1066
48. D. Locke, H. Chen, Y. Liu, C. Liu, and M. Kahn Lipid rafts orchestrate signaling by the platelet receptor glycoprotein VI J. Biol. Chem. 277 2002 18801 18809
49. P. Wonerow, A. Obergfell, J. Wilde, G. Bobe, N. Asazuma, T. Brdicka, and et al. Differential role of glycolipid-enriched membrane domains in glycoprotein VI- and integrin-mediated phospholipase Cγ2 regulation in platelets Biochem. J. 364 2002 755 765
50. A. Moscardó, J. Vallés, A. Latorre, and M. Santos The association of thromboxane A2 receptor with lipid rafts is a determinant for platelet functional responses FEBS Lett. 588 2014 3154 3159
51. Z. Raslan, and K. Naseem Compartmentalisation of cAMP-dependent signalling in blood platelets: the role of lipid rafts and actin polymerisation Platelets 26 2015 349 357
52. Z. Raslan, A. Aburima, and K.M. Naseem The spatiotemporal regulation of cAMP signaling in blood platelets - old friends and new players Front. Pharmacol. 6 2015 266
53. G. Jedlitschky, K. Tirschmann, L.E. Lubenow, H.K. Nieuwenhuis, J.W. Akkerman, A. Greinacher, and et al. The nucleotide transporter MRP4 (ABCC4) is highly expressed in human platelets and present in dense granules, indicating a role in mediator storage Blood 104 2004 3603 3610
54. G. Jedlitschky, M. Cattaneo, L. Lubenow, D. Rosskopf, A. Lecchi, A. Artoni, and et al. Role of MRP4 (ABCC4) in platelet adenine nucleotide-storage: evidence from patients with delta-storage pool deficiencies Am. J. Pathol. 176 2010 1097 1103
55. T. Mattiello, R. Guerriero, L. Lotti, E. Trifir, M. Felli, A. Barbarulo, and et al. Aspirin extrusion from human platelets through multidrug resistance protein-4-mediated transport: evidence of a reduced drug action in patients after coronary artery bypass grafting J. Am. Coll. Cardiol. 58 2011 752 761
56. M. Rius, J. Hummel-Eisenbeiss, and D. Keppler ATP-dependent transport of leukotrienes B4 and C4 by the multidrug resistance protein ABCC4 (MRP4) J. Pharmacol. Exp. Ther. 324 2008 86 94
57. S. Cheepala, A. Pitre, Y. Fukuda, K. Takenaka, Y. Zhang, Y. Wang, and et al. The ABCC4 membrane transporter modulates platelet aggregation Blood 126 2015 2307 2319
58. A. Borgognone, and F. Pulcinelli Reduction of cAMP and cGMP inhibitory effects in human platelets by MRP4-mediated transport Thromb. Haemost. 108 2012 955 962
59. L. Lien, Z. Chen, C. Chung, T. Yen, H. Chiu, D. Chou, and et al. Multidrug resistance protein 4 (MRP4/ABCC4) regulates thrombus formation in vitro and in vivo Eur. J. Pharmacol. 737 2014 159 167
60. J. Niessen, G. Jedlitschky, M. Grube, H. Kawakami, J. Kamiie, S. Ohtsuki, and et al. Expression of ABC-type transport proteins in human platelets Pharmacogenet. Genomics 20 2010 396 400
61. M. Sjolinder, S. Tornhamre, H.E. Claesson, J. Hydman, and J.A. Lindgren Characterization of a leukotriene C4 export mechanism in human platelets: possible involvement of multidrug resistance-associated protein 1 J. Lipid Res. 40 1999 439 446
62. M. Leggas, M. Adachi, G. Scheffer, D. Sun, P. Wielinga, G. Du, and et al. MRP4 confers resistance to topotecan and protects the brain from chemotherapy Mol. Cell. Biol. 24 2004 7612 7621
63. B. Decouture, E. Dreano, T. Belleville-Rolland, O. Kuci, B. Dizier, A. Bazaa, and et al. Impaired platelet activation and cAMP homeostasis in MRP4-deficient mice Blood 126 2015 1823 1831
64. M. Hiasa, N. Togawa, T. Miyaji, H. Omote, A. Yamamoto, and Y. Moriyama Essential role of vesicular nucleotide transporter in vesicular storage and release of nucleotides in platelets Physiol. Rep. 2 2014 e12034
65. C. Floyd, and A. Ferro Mechanisms of aspirin resistance Pharmacol. Ther. 141 2014 69 78
66. A. Gori, E. Grifoni, R. Valenti, B. Giusti, R. Paniccia, G. Parodi, and et al. High on-aspirin platelet reactivity predicts cardiac death in acute coronary syndrome patients undergoing PCI Eur. J. Intern. Med. 2 2016 [Epub ahead of print]
67. J. Eikelboom, G. Hankey, J. Thom, D. Bhatt, P. Steg, G. Montalescot, and et al. Incomplete inhibition of thromboxane biosynthesis by acetylsalicylic acid: determinants and effect on cardiovascular risk Circulation 118 2008 1705 1712
68. A.L. Frelinger, Y. Li, M.D. Linden, M.R. Barnard, M.L. Fox, D.J. Christie, and et al. Association of cyclooxygenase-1-dependent and -independent platelet function assays with adverse clinical outcomes in aspirin-treated patients presenting for cardiac catheterization Circulation 120 2009 2586 2596
69. J. Kissova, A. Bulikova, P. Ovesna, L. Bourkova, and M. Penka Increased mean platelet volume and immature platelet fraction as potential predictors of thrombotic complications in BCR/ABL negative myeloproliferative neoplasms Int. J. Hematol. 100 2014 429 436
70. C. Chen, and C.D. Klaassen Rat multidrug resistance protein 4 (MRP4, ABCC4): molecular cloning, organ distribution, postnatal renal expression, and chemical inducibility Biochem. Biophys. Res. Commun. 317 2004 46 53
71. I. Massimi, R. Guerriero, L. Lotti, V. Lulli, A. Borgognone, F. Romani, and et al. Aspirin influences megakaryocytic gene expression leading to upregulation of multidrug resistance protein-4 in human platelets Br. J. Clin. Pharmacol. 78 2014 1343 1353
72. I. Massimi, A. Ciuffetta, F. Temperilli, F. Ferrandino, A. Zicari, F. Pulcinelli, and et al. Multidrug resistance protein-4 influences aspirin toxicity in human cell line Mediat. Inflamm. 2015 2015 [Eub ahead of print]
73. F. Temperilli, M. Di Franco, I. Massimi, M.L. Guarino, M.P. Guzzo, G. Valesini, and et al. Nonsteroidal anti-inflammatory drugs in-vitro and in-vivo treatment and multidrug resistance protein 4 expression in human platelets Vasc. Pharmacol. 76 2015 11 17